Witryna7 sty 2014 · There are several tools used to detect IP in elderly people, 16 such as Beers’ criteria, 17 the Screening Tool of Older Persons’ potentially inappropriate Prescriptions (STOPP) and the Screening Tool to Alert doctors to Right Treatment (START), 18, 19 and the Improved Prescribing in the Elderly Tool (IPET). 20 WitrynaBackground: Elderly patients are particularly vulnerable to inappropriate prescribing, with increased risk of adverse drug reactions and consequently higher rates of …
Appropriate prescribing in the elderly: an investigation of two ...
WitrynaJako příklad lze uvést např. Improved Prescribing in the Elderly Tool (IPET)11/, který byl vyvinut Kanadským odborným panelem v roce 2000; ovšem ani tento neřeší nedostatečné předepiso-vání (underprescribing) a tento nástroj nebyl prospektivně sledován v rámci randomizovaných kontrolovaných studií, zda se jedná o efek - WitrynaThe identifying rates of inappropriate prescribing in elderly patients in hospital used validated screening tools: MAI, the Beers' criteria 2003, the IPET and HEDIS. Results: Data derived using the MAI indicated clearly that there was improved medication appropriateness over the three hospital stay stages (P < 0.001). philosopher\u0027s of
The improving prescribing for the elderly (ImPE) project - BMJ
Witryna25 sie 2024 · The aim of this study was the application of Beers, Screening Tool of Older People's Prescriptions (STOPP)/Screening Tool to Alert to Right Treatment (START) and Improving Prescribing in the Elderly Tool (IPET) criteria as key tool to improve the quality of prescribing. Methods A retrospective study was conducted using the … Witryna31 maj 2024 · Overall, most respondents had good knowledge of appropriate use of medicines in the elderly in the following therapeutic areas: non-steroidal anti-inflammatory drugs (NSAIDs) (90; 87.6%), centrally acting antihypertensives in the elderly (92; 87.6% and 76; 76.4%), the use of first generation sulfonylureas (81; … WitrynaInappropriate prescribing (IP) is a common and serious global healthcare problem in elderly people, leading to increased risk of adverse drug reactions (ADRs), polypharmacy being the main risk factor for both IP and ADRs. philosopher\\u0027s oi